Syndicat des Jeunes Biologistes Médicaux

Clinical Immunology

ScienceDirect RSS

Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”

Publication date: March 2021
Source: Clinical Immunology, Volume 224
Author(s): Rossella Talotta
SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency

Publication date: March 2021
Source: Clinical Immunology, Volume 224
Author(s): Nicolai S.C. van Oers, Natasha W. Hanners, Paul Sue, Victor Aquino, Quan-Zhen Li, John W. Schoggins, Christian A. Wysocki
Interrelations between COVID-19 and other disorders

Publication date: March 2021
Source: Clinical Immunology, Volume 224
Author(s): Amin Gasmi, Massimiliano Peana, Lyudmila Pivina, Shvetha Srinath, Asma Gasmi Benahmed, Yuliya Semenova, Alain Menzel, Maryam Dadar, Geir Bjørklund
Recent insights into the impact of immune dysfunction on reproduction in autoimmune thyroiditis

Publication date: March 2021
Source: Clinical Immunology, Volume 224
Author(s): Qian Zhu, Qian-Han Xu, Ting Xie, Li-Ling Wang, Hong Liu, Kahindo P. Muyayalo, Xiao-Bo Huang, Si-Jia Zhao, Ai-Hua Liao
Identification of a potent regulatory T cell epitope in factor V that modulates CD4+ and CD8+ memory T cell responses

Publication date: March 2021
Source: Clinical Immunology, Volume 224
Author(s): Anne S. De Groot, Amy Rosenberg, S.M. Shahjahan Miah, Gail Skowron, Brian J. Roberts, Sandra Lélias, Frances E. Terry, William D. Martin
Is it time to re-think juvenile-onset Rheumatic and Musculoskeletal Diseases? – First steps towards individualised treatments to meet agreed targets

Publication date: February 2021
Source: Clinical Immunology, Volume 223
Author(s): Liza J. McCann, Christian M. Hedrich
Severe and recurrent infections identify severe congenital neutropenia and primary immunodeficiencies in pediatric isolated neutropenia

Publication date: February 2021
Source: Clinical Immunology, Volume 223
Author(s): F. Saettini, P. Mantovani, P. De Lorenzo, A. Biondi, S. Bonanomi
Fatal SARS-CoV-2 infection in a male patient with Good's syndrome

Publication date: February 2021
Source: Clinical Immunology, Volume 223
Author(s): Maria Rosa Pozzi, Manuela Baronio, Maria Bianchi Janetti, Luisa Gazzurelli, Daniele Moratto, Marco Chiarini, Alessandro Plebani, Vassilios Lougaris
BTK inhibition modulates multiple immune cell populations involved in the pathogenesis of immune mediated nephritis

Publication date: February 2021
Source: Clinical Immunology, Volume 223
Author(s): Samantha A. Chalmers, Sayra J. Garcia, Deborah Webb, Leal Herlitz, Jay Fine, Elliott Klein, Meera Ramanujam, Chaim Putterman
Leukocyte glucocorticoid receptor expression and related transcriptomic gene signatures during early sepsis

Publication date: February 2021
Source: Clinical Immunology, Volume 223
Author(s): Jiabao Li, Miaorong Xie, Yanan Yu, Ziren Tang, Chenchen Hang, Chunsheng Li
HBV upregulated triggering receptor expressed on myeloid cells-1 (TREM-1) expression on monocytes participated in disease progression through NF-Kb pathway

Publication date: February 2021
Source: Clinical Immunology, Volume 223
Author(s): Xiaojuan Wu, Bei Cai, Wang Lu, Yang Fu, Bin Wei, Qian Niu, Zhenzhen Su, Yamei Li, Lanlan Wang
Endoplasmic reticulum stress exacerbates inflammation in chronic rhinosinusitis with nasal polyps via the transcription factor XBP1

Publication date: February 2021
Source: Clinical Immunology, Volume 223
Author(s): Min Li, Yadong Xie, Keqing Zhao, Kun Chen, Yujie Cao, Jia Zhang, Miaomiao Han, Li Hu, Rui He, Dehui Wang, Huabin Li
Expression of APOBEC family members as regulators of endogenous retroelements and malignant transformation in systemic autoimmunity

Publication date: February 2021
Source: Clinical Immunology, Volume 223
Author(s): Clio P. Mavragani, Kyriakos A. Kirou, Adrianos Nezos, Surya Seshan, Teresa Wild, Sharon M. Wahl, Haralampos M. Moutsopoulos, Mary K. Crow
A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis

Publication date: February 2021
Source: Clinical Immunology, Volume 223
Author(s): Nurhan Kasap, Velat Celik, Sakine Isik, Pakize Cennetoglu, Ayca Kiykim, Sevgi Bilgic Eltan, Ercan Nain, Ismail Ogulur, Dilek Baser, Emre Akkelle, Mehmet Halil Celiksoy, Burcu Kocamis, Funda Erol Cipe, Ayse Deniz Yucelten, Elif Karakoc-Aydiner, Ahmet Ozen, Safa Baris
Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort

Publication date: February 2021
Source: Clinical Immunology, Volume 223
Author(s): Hèctor Corominas, Ivan Castellví, Virginia Pomar, Rosa Antonijoan, Isabel Mur, Laia Matas, Ignasi Gich, Natividad de Benito, Ana Laiz, Diego Castillo, Laura Villamarin, David Filella, Ana Milena Millán, María Ángeles Quijada, Mireia Puig, Jordi Casademont, Pere Domingo
Influenza infection, SARS, MERS and COVID-19: Cytokine storm – The common denominator and the lessons to be learned

Publication date: February 2021
Source: Clinical Immunology, Volume 223
Author(s): Varvara A. Ryabkova, Leonid P. Churilov, Yehuda Shoenfeld
Immune modulating effects of receptor interacting protein 2 (RIP2) in autoinflammation and immunity

Publication date: February 2021
Source: Clinical Immunology, Volume 223
Author(s): Sigrun Ruth Hofmann, Leonie Girschick, Robert Stein, Felix Schulze
Peripheral blood hsa-circRNA5333-4: A novel biomarker for myasthenia gravis

Publication date: Available online 17 January 2021
Source: Clinical Immunology
Author(s): Jie Lv, Lu Ren, Sensen Han, Jing Zhang, Xue Zhao, Yingna Zhang, Hua Fang, Linyuan Zhang, Haonan Yang, Shumin Wang, Junhong Yang, Xinzheng Cui, Qingyong Zhang, Yunke Zhang, Feng Gao
Characterization of autoantibodies, immunophenotype and autoimmune disease in a prospective cohort of patients with idiopathic CD4 lymphocytopenia

Publication date: Available online 7 January 2021
Source: Clinical Immunology
Author(s): Cornelia D. Cudrici, Afroditi Boulougoura, Virginia Sheikh, Alexandra Freeman, Ornella Sortino, James D. Katz, Irini Sereti, Richard M. Siegel
Effects of dietary restriction on gut microbiota and CNS autoimmunity

Publication date: Available online 18 August 2020
Source: Clinical Immunology
Author(s): Claudia Cantoni, Yair Dorsett, Luigi Fontana, Yanjiao Zhou, Laura Piccio
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab

Publication date: Available online 8 August 2020
Source: Clinical Immunology
Author(s): L. Rapisarda, P. Valentino, S. Barone, C. Torti, V. La Gamba, F. Fortunato, I. Sammarra, A. Gambardella
Gut dysbiosis and multiple sclerosis

Publication date: Available online 10 March 2020
Source: Clinical Immunology
Author(s): Daisuke Noto, Sachiko Miyake
Role of diet in regulating the gut microbiota and multiple sclerosis

Publication date: Available online 7 March 2020
Source: Clinical Immunology
Author(s): John Michael S. Sanchez, Ana Beatriz DePaula-Silva, Jane E. Libbey, Robert S. Fujinami

Clinical Immunology

Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”

SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency

Interrelations between COVID-19 and other disorders

Recent insights into the impact of immune dysfunction on reproduction in autoimmune thyroiditis

Identification of a potent regulatory T cell epitope in factor V that modulates CD4+ and CD8+ memory T cell responses

Is it time to re-think juvenile-onset Rheumatic and Musculoskeletal Diseases? – First steps towards individualised treatments to meet agreed targets

Severe and recurrent infections identify severe congenital neutropenia and primary immunodeficiencies in pediatric isolated neutropenia

Fatal SARS-CoV-2 infection in a male patient with Good's syndrome

BTK inhibition modulates multiple immune cell populations involved in the pathogenesis of immune mediated nephritis

Leukocyte glucocorticoid receptor expression and related transcriptomic gene signatures during early sepsis

HBV upregulated triggering receptor expressed on myeloid cells-1 (TREM-1) expression on monocytes participated in disease progression through NF-Kb pathway

Endoplasmic reticulum stress exacerbates inflammation in chronic rhinosinusitis with nasal polyps via the transcription factor XBP1

Expression of APOBEC family members as regulators of endogenous retroelements and malignant transformation in systemic autoimmunity

A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis

Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort

Influenza infection, SARS, MERS and COVID-19: Cytokine storm – The common denominator and the lessons to be learned

Immune modulating effects of receptor interacting protein 2 (RIP2) in autoinflammation and immunity

Peripheral blood hsa-circRNA5333-4: A novel biomarker for myasthenia gravis

Characterization of autoantibodies, immunophenotype and autoimmune disease in a prospective cohort of patients with idiopathic CD4 lymphocytopenia

Effects of dietary restriction on gut microbiota and CNS autoimmunity

Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab

Gut dysbiosis and multiple sclerosis

Role of diet in regulating the gut microbiota and multiple sclerosis

Connexion

Recherche